Karla V. Ballman

Oct 31, 2024 | jamanetwork.com | Jann N. Sarkaria |Karla V. Ballman |Sani H. Kizilbash

Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial Key PointsQuestion  Does the polyadenosine diphosphate-ribose polymerase (PARP) inhibitor veliparib enhance the efficacy of temozolomide in patients with newly diagnosed, MGMT promoter hypermethylated glioblastoma?

Sep 12, 2024 | digitalcommons.library.tmc.edu | Kristin Huntoon |S Anderson |Karla V. Ballman |Erin L. Twohy

BACKGROUND: A recent phase III trial (NCT01372774) comparing use of stereotactic radiosurgery [SRS] versus whole-brain radiation therapy [WBRT] after surgical resection of a single brain metastasis revealed that declines in cognitive function were more common with WBRT than with SRS.

Sep 5, 2024 | jamanetwork.com | Ryan Sun |Wendy Chen |Karla V. Ballman |Ann H. Partridge

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer Wendy Y. Chen, MD; Karla V. Ballman, PhD; Ann H. Partridge, MD; Olwen M. Hahn, MD; Frederick M. Briccetti, MD; William J. Irvin, MD; Banu Symington, MD; Kala Visvanathan, MD; Paula R. Pohlmann, MD; Thomas H. Openshaw, MD; Anna Weiss, MD; Eric P. Winer, MD; Lisa A. Carey, MD; Michelle D.

Sep 5, 2024 | jamanetwork.com | Wendy Chen |Karla V. Ballman |Ann H. Partridge |Olwen M. Hahn

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer Wendy Y. Chen, MD; Karla V. Ballman, PhD; Ann H. Partridge, MD; Olwen M. Hahn, MD; Frederick M. Briccetti, MD; William J. Irvin, MD; Banu Symington, MD; Kala Visvanathan, MD; Paula R. Pohlmann, MD; Thomas H. Openshaw, MD; Anna Weiss, MD; Eric P. Winer, MD; Lisa A. Carey, MD; Michelle D. Holmes, MD Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer—Reply Wendy Y. Chen, MD, MPH; Karla V. Ballman, PhD; Michelle D.

Sep 5, 2024 | jamanetwork.com | Antonio Ghidini |Wendy Chen |Karla V. Ballman |Ann H. Partridge

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer Wendy Y. Chen, MD; Karla V. Ballman, PhD; Ann H. Partridge, MD; Olwen M. Hahn, MD; Frederick M. Briccetti, MD; William J. Irvin, MD; Banu Symington, MD; Kala Visvanathan, MD; Paula R. Pohlmann, MD; Thomas H. Openshaw, MD; Anna Weiss, MD; Eric P. Winer, MD; Lisa A. Carey, MD; Michelle D. Holmes, MD Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer—Reply Wendy Y. Chen, MD, MPH; Karla V. Ballman, PhD; Michelle D.